Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
NKTR
$73.02
-3.82%
NKTR · Nektar Therapeutics
$73.02
-2.90 (-3.82%)
At close · Aug 14
Market Cap
$2.49B
Shares
34.14M
All earnings calls
Earnings call · FY2022 Q1
Nektar Therapeutics Q1 FY2022 Earnings Call
Nektar Therapeutics Q1 FY2022 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$24.82M
+5% YoY
Diluted EPS
-$7.35
Net income
-$90.39M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed May 5, 2022 · complete as-filed document
SEC periodic report
10-Q report
Filed May 6, 2022 · complete as-filed document